A detailed history of North Star Investment Management Corp. transactions in Altimmune, Inc. stock. As of the latest transaction made, North Star Investment Management Corp. holds 14,100 shares of ALT stock, worth $116,325. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,100
Previous 13,100 7.63%
Holding current value
$116,325
Previous $87,000 1.15%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$5.5 - $8.1 $5,500 - $8,100
1,000 Added 7.63%
14,100 $86,000
Q2 2024

Aug 05, 2024

BUY
$5.91 - $10.23 $59,691 - $103,323
10,100 Added 336.67%
13,100 $87,000
Q1 2024

Apr 30, 2024

BUY
$8.22 - $13.81 $24,660 - $41,430
3,000 New
3,000 $30,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $404M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.